Patient Sample Information
Patient ID & Sample ID are unique patient and sample identifiers created for internal use by Pacific Edge Diagnostics.
Composite Score is derived from analysis of genes known to be associated with Transitional Cell Carcinomas (TCC). Composite Score Range is from - 4 to + 6.
The score represents a value that separates the two groups: those with TCC and those without. A score of less than 0.1 is Negative (no TCC detected). A score of 2.0 or greater is Positive (presence of TCC). Scores in the Suspicious zone indicate uncertainty and the patient will require ongoing clinical assessment.
Proliferation, Tumour Progression, Differentiation, Apoptosis, & Stromal Response represent the classes of activity for the five genes used in the Composite Score. As individual values, these scores provide more information on specific gene activity. The lower these scores, the more strongly the indication of TCC.
Urine Concentration (Pass or Fail). – “Fail” means that urine was too dilute to effectively measure the genes.*
Urine Blood Content (Pass or Fail) – “Fail” when blood content is too high and could interfere with the test.**
Suggest Sample Retest (Yes or No) – “Yes” for any condition in which results are inconclusive, including above. The frequency of retesting is expected to be very low and may be affected by clinical practice.
*If the patient provides a noticeably dilute sample, and informs you that they have consumed excessive liquid prior to their visit, an additional sample may be advised.
**If the patient provides a sample with visible levels of blood, you may wish to request an additional sample from them at a later date.
Comments for individual reports are automatically generated by the system in response to the Composite Score ranges; Negative,Suspicious, and Positive. Additional comments may be added by laboratory personnel. These results are adjunctive to the ordering healthcare provider's work up.